R&D

The institute was founded in 1985 as the ‘Biotechnology Centre’ of Indian Agricultural Research Institute (IARI) for molecular biology and biotechnology research in crop plants. The prescience of the role of biotechnology in agriculture led to a bigger responsibility for this centre and it was elevated as National Research Centre on Plant Biotechnology in the year 1993 (Now NIPB).

Post : Research Associate

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Research Scientist - I

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Junior Research Fellow (One)

The mandate of the Institute is to address the reproductive health issues of national and global relevance. The institute was established with an objective to develop novel and efficacious modalities for fertility regulation through research and thereby assist the government in its mission to stem the population boom. In the past four decades, however, the institute has grown beyond the mandate with which it was entrusted at the time of its genesis.

MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine API and five finished dosage facilities established across Hyderabad, USA and Myanmar. Innovation and speed form the crux of our business strategy.

Post : Research & Development Executive

Experience : 1-5 Years
Qualification : M.Sc | Organic Chemistry

The Chung research group focuses on drug delivery and gene therapy, nanomedicine, and biomaterials to generate strategies to address the limitations of clinical solutions. A major focus of our work is regarding rare and genetic diseases. In particular, we are interested in biomimetic nanoparticles that can be designed to cross biological barriers and deliver molecular signals to report back on or influence the behavior of diseased tissue.

The mandate of the Institute is to address the reproductive health issues of national and global relevance. The institute was established with an objective to develop novel and efficacious modalities for fertility regulation through research and thereby assist the government in its mission to stem the population boom. In the past four decades, however, the institute has grown beyond the mandate with which it was entrusted at the time of its genesis.

The U.S. Pharmacopeial Convention (USP) USP is an independent scientific organization that collaborates with the world's top experts in health and science to develop quality standards for medicines, dietary supplements, and food ingredients. USP's fundamental belief that Equity = Excellence manifests in our core value of Passion for Quality through our more than 1,100 talented professionals across five global locations to deliver the mission to strengthen the supply of safe, quality medicines and supplements worldwide.

The mandate of the Institute is to address the reproductive health issues of national and global relevance. The institute was established with an objective to develop novel and efficacious modalities for fertility regulation through research and thereby assist the government in its mission to stem the population boom. In the past four decades, however, the institute has grown beyond the mandate with which it was entrusted at the time of its genesis.